Iterum Therapeutics Plc (ITRM) with a beta value of 2.27 appears to be a promising investment opportunity.
A new trading day began on Monday, with Iterum Therapeutics Plc (NASDAQ: ITRM) stock price up 3.65% from the previous day of trading, before settling